Related Experiment Video
Updated: Mar 18, 2026
Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
Published on: June 18, 2015
Tamoxifen Therapy for Breast Cancer and Endometrial Pathology
Sps Kochar1, P Arora2, A B Chattopadhyay3
1Reader (Obstetric and Gynaecology), Armed Forces Medical College, Pune.
Background:
Tamoxifen, used as adjuvant therapy for carcinoma breast in postmenopausal women to prevent relapse has estrogenic effect on the endometrium.
Methods:
104 patients on tamoxifen for more than six months were subjected to a clinical examination and transvaginal sonography. Patients with endometrial thickness > 8 mm were further evaluated by hysteroscopy and endometrial biopsy.
Results:
35(34%) patients were symptomatic. The average endometrial thickness was 11.2 mm which correlated with duration of tamoxifen use. 27(48%) patients had abnormal hysteroscopic findings. 35 (63%) of endometrial biopsies revealed abnormal endometrium. One case of endometrial carcinoma was diagnosed. The results were statistically analysed. There is a significant association between symptomatic status and endometrial thickness and duration of tamoxifen use.
Conclusion:
All patients on long term tamoxifen should be annually screened for endometrial pathology.
